BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28062667)

  • 21. Restoration of SMN to Emx-1 expressing cortical neurons is not sufficient to provide benefit to a severe mouse model of Spinal Muscular Atrophy.
    Taylor AS; Glascock JJ; Rose FF; Lutz C; Lorson CL
    Transgenic Res; 2013 Oct; 22(5):1029-36. PubMed ID: 23512182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy.
    Xu CC; Denton KR; Wang ZB; Zhang X; Li XJ
    Dis Model Mech; 2016 Jan; 9(1):39-49. PubMed ID: 26586529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy.
    Villalón E; Kline RA; Smith CE; Lorson ZC; Osman EY; O'Day S; Murray LM; Lorson CL
    Hum Mol Genet; 2019 Nov; 28(22):3742-3754. PubMed ID: 31363739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival motor neuron protein regulates oxidative stress and inflammatory response in microglia of the spinal cord in spinal muscular atrophy.
    Ando S; Osanai D; Takahashi K; Nakamura S; Shimazawa M; Hara H
    J Pharmacol Sci; 2020 Dec; 144(4):204-211. PubMed ID: 33070839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
    Liu H; Beauvais A; Baker AN; Tsilfidis C; Kothary R
    Dev Neurobiol; 2011 Feb; 71(2):153-69. PubMed ID: 20862739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
    d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
    Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway.
    D'Amico D; Biondi O; Januel C; Bezier C; Sapaly D; Clerc Z; El Khoury M; Sundaram VK; Houdebine L; Josse T; Della Gaspera B; Martinat C; Massaad C; Weill L; Charbonnier F
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12816. PubMed ID: 35338505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons.
    Garcera A; Mincheva S; Gou-Fabregas M; Caraballo-Miralles V; Lladó J; Comella JX; Soler RM
    Neurobiol Dis; 2011 Jun; 42(3):415-26. PubMed ID: 21333739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothermia improves disease manifestations in SMA mice via SMN augmentation.
    Tsai LK; Chen CL; Tsai YC; Ting CH; Chien YH; Lee NC; Hwu WL
    Hum Mol Genet; 2016 Feb; 25(4):631-41. PubMed ID: 26647309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac defects contribute to the pathology of spinal muscular atrophy models.
    Shababi M; Habibi J; Yang HT; Vale SM; Sewell WA; Lorson CL
    Hum Mol Genet; 2010 Oct; 19(20):4059-71. PubMed ID: 20696672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal muscular atrophy: going beyond the motor neuron.
    Hamilton G; Gillingwater TH
    Trends Mol Med; 2013 Jan; 19(1):40-50. PubMed ID: 23228902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocytes influence the severity of spinal muscular atrophy.
    Rindt H; Feng Z; Mazzasette C; Glascock JJ; Valdivia D; Pyles N; Crawford TO; Swoboda KJ; Patitucci TN; Ebert AD; Sumner CJ; Ko CP; Lorson CL
    Hum Mol Genet; 2015 Jul; 24(14):4094-102. PubMed ID: 25911676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.
    Passini MA; Bu J; Richards AM; Treleaven CM; Sullivan JA; O'Riordan CR; Scaria A; Kells AP; Samaranch L; San Sebastian W; Federici T; Fiandaca MS; Boulis NM; Bankiewicz KS; Shihabuddin LS; Cheng SH
    Hum Gene Ther; 2014 Jul; 25(7):619-30. PubMed ID: 24617515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy.
    Murray LM; Lee S; Bäumer D; Parson SH; Talbot K; Gillingwater TH
    Hum Mol Genet; 2010 Feb; 19(3):420-33. PubMed ID: 19884170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage.
    Jangi M; Fleet C; Cullen P; Gupta SV; Mekhoubad S; Chiao E; Allaire N; Bennett CF; Rigo F; Krainer AR; Hurt JA; Carulli JP; Staropoli JF
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2347-E2356. PubMed ID: 28270613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyper-SUMOylation of SMN induced by SENP2 deficiency decreases its stability and leads to spinal muscular atrophy-like pathology.
    Zhang Y; Chen X; Wang Q; Du C; Lu W; Yuan H; Zhang Z; Li D; Ling X; Ren X; Zhao Y; Su Q; Xing Z; Qin Y; Yang X; Shen Y; Wu H; Qi Y
    J Mol Med (Berl); 2021 Dec; 99(12):1797-1813. PubMed ID: 34628513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms and animal models of spinal muscular atrophy.
    Edens BM; Ajroud-Driss S; Ma L; Ma YC
    Biochim Biophys Acta; 2015 Apr; 1852(4):685-92. PubMed ID: 25088406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice.
    Deguise MO; De Repentigny Y; McFall E; Auclair N; Sad S; Kothary R
    Hum Mol Genet; 2017 Feb; 26(4):801-819. PubMed ID: 28108555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.